Angiotensin II type 2 receptor gene polymorphisms in cardiovascular disease

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 11, Issue 1, 2010, Pages 79-85

  Balmforth, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Angiotensin II; AT2 receptor; CAD; Human studies; LVH; Polymorphism

Indexed keywords

ANGIOTENSIN 2 RECEPTOR;

ALLELE; CARDIOVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY RECANALIZATION; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HORMONE ACTION; HUMAN; NONHUMAN; REVIEW; SEQUENCE ANALYSIS; SODIUM BALANCE;

ATHEROSCLEROSIS; CARDIOMEGALY; CARDIOVASCULAR DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 77749254983     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309347782     Document Type: Review

References (44)

1. Levy BI How to explain the differences between renin angiotensin system modulators. Am J Hypertens 2005 ; 18: 134S - 41S.
2. de Gesparo M., Catt KJ, Inagami T., Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000 ; 52: 415-472.
3. Steckelings UM, Kaschina E., Unger T. The AT2 receptor- a matter of love and hate. Peptides 2005 ; 26: 1401-1409.
4. Carey RM, Padia SH Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure. Trends Endocrinol Metab 2008 ; 19: 84-87.
5. Pajukanta P., Cargill M., Viitanen L. et al. Two loci on chromosome 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 2000 ; 67: 1481-1493.
6. Martin MM, Elton TS The sequence and genomic organization of the human type 2 angiotensin II receptor. Biochem Biophys Res Commun 1995 ; 209: 554-562.
7. Warnecke C., Willich T., Holzmeister J., Bottari S., Fleck E., Regitz-Zagrosek V. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements. Biochem J 1999 ; 340: 17-24.
8. Plummer S., Tower C., Alonso P. et al. Haplotypes of the angiotensin II receptor genes AGTR1 and AGTR2 in women with normotensive pregnancy and women with preeclampsia. Hum Mutat 2004 ; 24: 14-20.
9. Nishimura H., Yerkes E., Hohenfellner K. et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary track, CAKUT, of mice and men. Mol Cell 1999 ; 3: 1-10.
10. Hiraoka M., Taniguchi T., Nakai H. et al. No evidence for AT2R gene derangement in human urinary tract anomalies. Kidney Int 2001 ; 59: 1244-1249.
11. Siomou E., Bouba I., Kollios KD et al. Angiotensin II type 2 receptor gene polymorphism in Caucasian children with a wide spectrum of congenital anomalies of kidney and urinary tract. Pediatr Res 2007 ; 62: 83-87.
12. Warnecke C., Surder D., Curth R., Fleck E., Regitz-Zagrosek V. Analysis and functional characterization of alternatively spliced angiotensin II type 1 and 2 receptor transcripts in the human heart. J Mod Med 1999 ; 77: 718-727.
13. Warnecke C., Mugrauer P., Surder D., Erdmann J., Schubert C., Regitz-Zagrosek V. Intronic Ang II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing. Am J Physiol Regul Integr Comp Physiol 2005 ; 289: R1729-35.
14. Tsutsumi Y., Matsubara H., Ohkubo N. et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998 ; 83: 1035-1046.
15. Wharton J., Morgan K., Rutherford RA et al. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J Pharmacol Exp Ther 1998: 284: 323-336.
16. Sales VL, Sukhova GK, Lopez-Ilasaca MA, Libby P., Dzau VJ, Pratt RE Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 2005 ; 112: 3328-3336.
17. van Kesteren CA, van Heugten HA, Lamers JM, Saxena PR, Schalekamp MA, Danser AH Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol 1997 ; 29: 2147-2157.
18. Booz GW Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system. Hypertension 2005 ; 45: 341-346.
19. Senbonmatsu T., Ichihara S., Price E. Jr, Gaffney FA, Inagami T. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000 ; 106: R25-9.
20. Ichihara S., Senbonmatsu T., Price E. Jr, Ichiki T., Gaffney FA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001 ; 104: 346-351.
21. Oishi Y., Ozono R., Yano Y. et al. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension 2003 ; 41: 814-818.
22. Kurisu S., Ozono R., Oshima T. et al. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 2003 ; 41: 99-107.
23. Falcon BL, Stewart JM, Bourassa E. et al. Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. Physiol Genomics 2004 ; 19: 255-261.
24. Metcalfe BL, Huentelman MJ, Parilak LD et al. Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer. Hypertension 2004 ; 43: 1233-1238.
25. Schmieder RE, Erdmann J., Delles C. et al. Effect of the angiotensin II type 2-receptor gene (+1675G/A) on left ventricular structure in humans. J Am Coll Cardiol 2001 ; 37: 175-182.
26. Herrmann S-M., Nicaud V., Schmidt-Petersen K. et al. Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies. Eur J Heart Fail 2002 ; 4: 707-712.
27. Kuznetsova T., Staessen JA, Thijs L. et al.; European Project On Genes in Hypertension (EPOGH) Investigators. Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation 2004 ; 110: 2644-2650.
28. Ott C., Titze S., Schwarz TK et al. High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene. J Hypertens 2007 ; 25: 1627-1632.
29. Miyaki K., Hara A., Araki J. et al. C3123A polymorphism of the angiotensin II type 2 receptor gene and salt sensitivity in healthy Japanese men. J Hum Hypertens 2006 ; 20: 467-469.
30. Zivkovic M., Djuric T., Stancic O., Alavantic D., Stankovic A. X-linked angiotensin II type 2 receptor gene polymorphism -1332A/G in male patients with essential hypertension. Clin Chim Acta 2007 ; 386: 110-113.
31. Alfakih K., Maqbool A., Sivananthan M. et al. Left ventricular mass index and the common, functional, X-linked angiotensin II type-2 receptor gene polymorphism (-1332 G/A) in patients with systemic hypertension. Hypertension 2004 ; 43: 1189-1194.
32. Ozono R., Wang Z. -Q, Moore AF, Inagam T., Siragy HM, Carey RM Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1997 ; 30: 1238-1246.
33. Pinaud F., Bocquet A., Dunmont O. et al. Paradoxical role of angiotensin type 2 receptors in resistance arteries of old rats. Hypertension 2007 ; 50: 96-102.
34. Nakajima M., Hutchinson HG, Fujinaga M. et al. The angiotensin II type 2 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A 1995 ; 92: 10663-10667.
35. Stoll M., Steckelings UM, Paul M., Bottari SP, Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995 ; 95: 651-657.
36. Akishita M., Horiuchi M., Yamada H. et al. Inflammation influences vascular remodelling through AT2 receptor expression and signalling. Physiol Genomics 2000 ; 2: 13-20.
37. Wu L., Iwai M., Nakagami H. et al. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 2001 ; 104: 2716-2721.
38. Iwai M., Chen R., Li Z. et al. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 2005 ; 112: 1636-1643.
39. Hu C., Dandapat A., Chen J. et al. Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression. Atherosclerosis 2008 ; 199: 288-294.
40. Dandapat A., Hu CP, Chen J. et al. Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaques. Biochem Biophys Res Commun 2008 ; 366: 871-877.
41. Davies MJ Coronary disease: the pathophysiology of acute coronary syndromes. Heart 2000 ; 83: 361-366.
42. Jones A., Dhamrait SS, Payne JR et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 2003 ; 42: 500-506.
43. Alfakih K., Lawrance RA, Maqbool A. et al. The clinical significance of a common, functional, X-linked angiotensin II type-2 receptor gene polymorphism (-1332 G/A) in a cohort of 509 families with premature coronary artery disease. Eur Heart J 2005 ; 26: 548-589.
44. Alfakih K., Brown B., Lawrance RA et al. Effect of a common X-linked angiotensin II type-2 receptor gene polymorphism (-1332 G/A) on the occurrence of premature myocardial infarction and stenotic atherosclerosis requiring revascularization. Atherosclerosis 2007 ; 195: E32-8.